At Tuesday’s closing price, Mankind Pharma was valued at a price-to-earnings ratio of 43 times its FY22 earnings. Mankind is now India’s fifth largest pharma company by market value of ₹57,046 crore. Sun Pharma, Divi’s Lab, Dr. Reddy’s Lab, and Cipla are currently valued between ₹75,284 crore and ₹2.31 lakh crore.
Mid- to high-teens earnings growth for next 2 years likely: Shibani Sircar Kurian
Shibani Sircar Kurian of Kotak Mahindra AMC provides insights on Nifty valuations, earnings stability, sector-specific investments, and market volatility. The analysis covers strong Nifty valuations